Literature DB >> 19693945

(99m)Tc-sestamibi scanning in thyroid nodules with nondiagnostic cytology.

Luca Giovanella1, Sergio Suriano, Marco Maffioli, Luca Ceriani, Giuseppe Spriano.   

Abstract

BACKGROUND: Our aim in this study was to assess the relevance of (99m)Tc-sestaMIBI (MIBI) scan in the diagnostic evaluation of thyroid nodules with nondiagnostic cytology.
METHODS: In all, 74 patients with a single nodule and repeatedly nondiagnostic ultrasound-guided fine-needle aspiration cytology (US-FNAC) were enrolled. In all cases thyroid nodules were cold in (99m)Tc-pertechnetate (Tc) scans. Thyroid scans were also acquired 30 and 120 minutes after intravenous administration of MIBI. Nodules that concentrate MIBI were considered as positive (ie, suspicious for malignancy). Histologic findings were obtained after surgery in all patients.
RESULTS: No differences occurred in early and late MIBI images. None of 63 patients with a negative MIBI scan had a final histologic diagnosis of malignancy (ie, no false-negative results). Two patients with a final histologic diagnosis of papillary thyroid carcinoma (PTC) and 1 with follicular thyroid carcinoma (FTC) had a positive MIBI scan. Eight patients with a final histologic diagnosis of benign lesions (3 with follicular adenomas) also had MIBI-positive scans. The sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) were, respectively, 100%, 88%, 89%, 27%, and 100%.
CONCLUSIONS: A negative MIBI scan in a cold nodule accurately excludes malignancy when US-FNAC is reported as nondiagnostic. This avoids the need for more invasive diagnostic procedures (ie, surgery) and positively influences the cost-effectiveness profile. A MIBI scan may be performed by acquiring images 30 minutes after tracer administration alone. Histology is still necessary to distinguish benign from malignant disease in a MIBI-positive nodule but unnecessary surgery could have been reduced from 71 to 8 cases in our series.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19693945     DOI: 10.1002/hed.21229

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  16 in total

1.  Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer.

Authors:  Frederik A Verburg; Cumali Aktolun; Arturo Chiti; Savvas Frangos; Luca Giovanella; Martha Hoffmann; Ioannis Iakovou; Jasna Mihailovic; Bernd J Krause; Werner Langsteger; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-17       Impact factor: 9.236

2.  Cost-effectiveness of (99m)Tc-MIBI in the evaluation of thyroid nodules for malignancy: a new lease of life for an old radiopharmaceutical?

Authors:  Frederik A Verburg; Florian F Behrendt; Felix M Mottaghy; Alexander Heinzel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-11       Impact factor: 9.236

3.  Increasing Importance.

Authors:  Tim Scholz
Journal:  Dtsch Arztebl Int       Date:  2017-01-09       Impact factor: 5.594

4.  Diagnostic performance of (99m)Tc-MIBI scan in predicting the malignancy of thyroid nodules: a meta-analysis.

Authors:  Giorgio Treglia; Carmelo Caldarella; Enrico Saggiorato; Luca Ceriani; Fabio Orlandi; Massimo Salvatori; Luca Giovanella
Journal:  Endocrine       Date:  2013-03-26       Impact factor: 3.633

5.  The clinical management in familial adenomatous polyposis deserves continuous monitoring for thyroid carcinoma.

Authors:  Stefano Crippa; Piercarlo Saletti; Jessica Barizzi; Luca Mazzucchelli
Journal:  BMJ Case Rep       Date:  2012-11-15

6.  Management of thyroid nodules incidentally discovered on MIBI scanning for primary hyperparathyroidism.

Authors:  Tristan Greilsamer; Claire Blanchard; Niki Christou; Delphine Drui; Catherine Ansquer; Maelle Le Bras; Bertrand Cariou; Cécile Caillard; Emmanuelle Mourrain-Langlois; Anne Sophie Delemazure; Muriel Mathonnet; Françoise Kraeber-Bodéré; Eric Mirallié
Journal:  Langenbecks Arch Surg       Date:  2015-02-20       Impact factor: 3.445

Review 7.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

8.  Combined (99m)Tc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules.

Authors:  Anita Wale; Kenneth A Miles; Barnaby Young; Charles Zammit; Anthony Williams; John Quin; Sabina Dizdarevic
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-13       Impact factor: 9.236

9.  18F-Fluorocholine Positron Emission Tomography/Computed Tomography is a Highly Sensitive but Poorly Specific Tool for Identifying Malignancy in Thyroid Nodules with Indeterminate Cytology: The Chocolate Study.

Authors:  Renaud Ciappuccini; Idlir Licaj; Audrey Lasne-Cardon; Emmanuel Babin; Dominique de Raucourt; David Blanchard; Vianney Bastit; Virginie Saguet-Rysanek; Justine Lequesne; Damien Peyronnet; Jean-Michel Grellard; Bénédicte Clarisse; Stéphane Bardet
Journal:  Thyroid       Date:  2020-12-23       Impact factor: 6.568

Review 10.  Imaging of multidrug resistance in cancer.

Authors:  S Dizdarevic; A M Peters
Journal:  Cancer Imaging       Date:  2011-03-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.